Short Wave Pharma Overview

Short Wave Pharma is a biopharmaceutical company developing novel formulations of psilocybin and additional APIs, along with customized delivery methods, for patients living with mental health disorders, neurodegenerative diseases, chronic pain, and any other medical conditions for which psilocybin is known to have a positive effect.

Short Wave Pharma has begun preclinical studies related to its product for anorexia nervosa. The company’s future programs include the development of novel formulations and delivery approaches for chronic pain and neurodegenerative diseases.

Cumulative Funding Raised Over Time ($)

Employees Over Time

Biopharma company Short Wave partnering in clinical trial for eating disorders with Sheba Fund | CTech

#Partners #Customers

Companies you might be interested in

Driven by Finder AI

Gynica
Women's Health Innovation

1-10 employees • Funding Stage: Seed

shared sectors

Drug Delivery, Drugs Discovery & Development

Also shared

drug-delivery pharmaceuticals

Are these companies similar?
MyBiotics Pharma
Clinically Effective Microbiome and Probiotic Products

11-50 employees • Funding Stage: A

shared sectors

Drug Delivery, Drugs Discovery & Development

Also shared

drug-delivery pharmaceuticals

Are these companies similar?
Ayana Pharma
Liposomal Drugs for Cancer Treatment

11-50 employees • Funding Stage: Mature

shared sectors

Drug Delivery, Drugs Discovery & Development

Also shared

drug-delivery pharmaceuticals

Are these companies similar?
Entera Bio
Oral Delivery of Therapeutic Proteins

11-50 employees • Funding Stage: Public

shared sectors

Drug Delivery, Drugs Discovery & Development

Also shared

drug-delivery pharmaceuticals

Are these companies similar?